The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
It is a pilot study to explore the efficacy and safety of Tacrolimus Sustained-release
Capsules (ADVAGRAF) on 6-month induction therapy of Refractory Nephrotic Syndrome (RNS).